CD8A and sarcoma: These data directly contrast observations made by Alspach et al. in a bilateral T3>KP sarcoma tumor model in which opposing MHC II− tumors expressing a single CD8+ T cell epitope versus dual CD4+/CD8+ T cell epitopes only led to clearance of the latter tumor after ICB (71).